Long-term results of triple-drug-based immunosuppression in nonneonatal pediatric heart transplant recipients

Transplantation

Volumn 65, Issue 11, 1998, Pages 1470-1476

  Gajarski, Robert J ^a,c   Smith, E O'Brian ^a   Denfield, Susan W ^a   Rosenblatt, Howard M ^a   Kearney, Debra ^a   Frazier, O H ^b   Radovancevic, Branislav ^b   Price, Julia K ^a   Kertesz, Naomi J ^a   Towbin, Jeffrey A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS HEART INSTITUTE   (United States)

^c TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; PREDNISONE;

ADOLESCENT; ADULT; ALLOGRAFT; ARTICLE; CHILD; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; LUNG VASCULAR RESISTANCE; LYMPHOPROLIFERATIVE DISEASE; MALE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RECIPIENT; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AZATHIOPRINE; CHILD; CHILD, PRESCHOOL; CORONARY DISEASE; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; INFANT; INFECTION; LONGITUDINAL STUDIES; MALE; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PREDNISONE; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 0032525861     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199806150-00011     Document Type: Article

References (28)

1. Hosenpud JD, Novick RJ, Breen TJ, Daily P. The Registry of the International Society for Heart and Lung Transplantation: twelfth official report (1995). J Heart Lung Transplant 1995; 14: 805.
2. Bailey LL. Role of cardiac replacement in the neonate. Heart Transplant 1985; 4: 506.
3. Pennington DG, Sarafian J, Swartz M. Heart transplantation in children. Heart Transplant 1985; 4: 441.
4. Fricker FJ, Griffith BP, Hardesty RL, et al. Experience with heart transplantation in children. Pediatrics 1987; 79: 138.
5. Webber SA, Fricker FJ, Michaels M, et al. Orthotopic heart transplantation in children with congenital heart disease. Ann Thorac Surg 1994; 58: 1664.
6. Chartrand C. Pediatric cardiac transplantation despite atrial and venous return anomalies. Ann Thorac Surg 1991; 52: 716.
7. Doty DB, Renlund DG, Caputo GR, Burton NA, Jones KW. Cardiac transplantation in situs inversus. J Thorac Cardiovasc Surg 1990; 99: 493.
8. McAllister HA, Schnee MJM, Radovancivic B, Frazier OH. A system for grading cardiac allograft rejection. Texas Heart Inst J 1986; 13: 1.
9. Billingham ME, Cary N, Hammond ME. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. J Heart Lung Transplant 1990; 9: 587.
10. Gajarski RJ, Towbin JA, Bricker JT, et al. Intermediate follow-up of pediatric heart transplant recipients with elevated pulmonary vascular resistance index. J Am Coll Cardiol 1994; 23: 1682.
11. Gajarski RJ, Towbin JA, Garson A. Fontan palliation vs. cardiac transplantation: a cost comparison. Am Heart J 1996; 131: 1169.
12. Schowengerdt KO, Ni J, Denfield SW, et al. Diagnosis, surveillance, and epidemiologic evaluation of viral infections in pediatric cardiac transplant recipients with the use of the polymerase chain reaction. J Heart Lung Transplant 1996; 15: 111.
13. Gajarski RJ, Rosenblatt H, Denfield SW, Schowengerdt KO, Price JK, Towbin JA. Outcomes among pediatric heart transplant recipients of CMV positive donor organs following dual therapy CMV prophylaxis. Tex Heart Inst J 1997; 24: 97.
14. Canter CE, Saffitz JE, Moorhead S, Gutierrez FR Bolman RM, Spray TL. Early results after pediatric cardiac transplantation with triple immunosuppression therapy. Am J Cardiol 1993; 71: 971.
15. Slaughter MS, Braunlin E, Bolman M, Molina JE, Shumway SJ. Pediatric heart transplantation: results of 2- and 5-year follow-up. J Heart Lung Transplant 1994; 13: 624.
16. Sigfusson G, Fricker FJ, Bernstein D, et al. Long-term survivors of pediatric heart transplantation: a multicenter report of sixty-eight children who have survived longer than five years. J Pediatr 1997; 130: 862.
17. Addonizio LJ. Late complications of pediatric cardiac transplantation [Brief Review]. ACC Curr J Rev 1994; 3(6): 23.
18. Penn I. Incidence and treatment of neoplasia after transplantation. J Heart Lung Transplant 1993; 12: S328.
19. Starzl TE, Porter KA, Iwatsuki S, et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporine-steroid therapy. Lancet 1984; 1: 583.
20. Sullivan JL, Medveczky P, Forman SJ, Baker SM, Monroe JE, Mulder C. Epstein-Barr virus induced lymphoproliferation: implications for antiviral chemotherapy. N Engl J Med 1984; 311: 1163.
21. Pahl E, Zales VR, Fricker FJ, Addonizio LJ. Posttransplant coronary artery disease in children. Circulation 1994; 90: II-56.
22. Kobashigawa JA, Miller L, Yeung A, et al. Does acute rejection correlate with the development of transplant coronary artery disease? A multicenter study using intravascular ultrasound J Heart Lung Transplant 1995; 14: S221.
23. Radovancevic B, Poindexter S, Birovljev S, et al. Risk factors for development of accelerated coronary artery disease in cardiac transplant recipients. Eur J Cardiothorac Surg 1990; 4: 309.
24. Uretsky BF, Murali S, Reddy PS, et al. Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone Circulation 1987; 76: 27.
25. Canter CE, Moorhead S, Saffitz JE, Huddleston CB Spray TL. Steroid withdrawal in the pediatric heart transplant recipient initially treated with triple immunosuppression. J Heart Lung Transplant 1994; 13: 74.
26. Olivari M, Jessen ME, Baldwin BJ, et al. Triple-drug immunosuppression with steroid discontinuation by six months after heart transplantation. J Heart Lung Transplant 1995; 14: 127.
27. Okerecke OUJ, Frazier OH, Bricker JT, et al. Growth in children after cardiac transplantation. Texas Heart Inst J (in press).
28. Addonizio LJ, Hsu DT, Douglas JF, et al. Decreasing incidence of coronary disease in pediatric cardiac transplant recipients using increased immunosuppression. Circulation 1993; 88 (part II): 224.